{
     "PMID": "8186771",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19940617",
     "LR": "20131121",
     "IS": "0969-8043 (Print) 0969-8043 (Linking)",
     "VI": "45",
     "IP": "4",
     "DP": "1994 Apr",
     "TI": "p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition- reconstitution approach to vesamicol receptor radioligands for positron emission tomography.",
     "PG": "465-72",
     "AB": "Current methods of radioligand synthesis for the vesamicol receptor either utilize bioactive unlabeled precursors and/or generate unlabelled bioactive by-products. The presence of these compounds in the radiotracer preparation increases the risk of adverse pharmacological reactions in animals. To eliminate the risk of such reactions, we have synthesized the novel radioligand [18F]FBT from two inactive precursors, [18F]fluorobenzyl iodide and trozamicol. (+)- and (-)-[18F]FBT were synthesized in 57-85% yield, from [18F]fluorbenzyl iodide and (+)- and (-)-trozamicol, respectively. In the rat brain, comparable levels of (-)-[18F]FBT were found in the striatum, cortex, cerebellum and hippocampus during a 3 h period. In contrast, the striatum:cerebellum, cortex:cerebellum and hippocampus:cerebellum ratios for (+)-[18F]FBT increased from unity at 5 min post-injection to 2.8, 1.4 and 1.7, respectively, at 3 h. Therefore, (+)-[18F]FBT may be potentially useful for mapping vesamicol receptor density in vivo.",
     "FAU": [
          "Efange, S M",
          "Mach, R H",
          "Khare, A",
          "Michelson, R H",
          "Nowak, P A",
          "Evora, P H"
     ],
     "AU": [
          "Efange SM",
          "Mach RH",
          "Khare A",
          "Michelson RH",
          "Nowak PA",
          "Evora PH"
     ],
     "AD": "Department of Radiology, University of Minnesota, Minneapolis 55455.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "England",
     "TA": "Appl Radiat Isot",
     "JT": "Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine",
     "JID": "9306253",
     "RN": [
          "0 (Fluorine Radioisotopes)",
          "0 (Fluorobenzenes)",
          "0 (Piperidines)",
          "0 (Receptors, Cholinergic)",
          "0 (vesamicol receptor)",
          "154824-77-8 (4-fluorobenzyltrozamicol)",
          "J6292F8L3D (Haloperidol)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/drug effects/*metabolism",
          "Cerebellum/metabolism",
          "Cerebral Cortex/metabolism",
          "Corpus Striatum/metabolism",
          "Fluorine Radioisotopes",
          "*Fluorobenzenes",
          "Haloperidol/pharmacology",
          "Hippocampus/metabolism",
          "Isotope Labeling",
          "Male",
          "Piperidines/*chemical synthesis/pharmacokinetics",
          "Rats",
          "Receptors, Cholinergic/analysis/*metabolism",
          "Time Factors"
     ],
     "EDAT": "1994/04/01 00:00",
     "MHDA": "1994/04/01 00:01",
     "CRDT": [
          "1994/04/01 00:00"
     ],
     "PHST": [
          "1994/04/01 00:00 [pubmed]",
          "1994/04/01 00:01 [medline]",
          "1994/04/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Appl Radiat Isot. 1994 Apr;45(4):465-72.",
     "term": "hippocampus"
}